Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

SAN DIEGO, California – When introduced to the U.S. market in the summer of 1998, many industry observers expected that transmyocardial revascularization (TMR) would be adopted rapidly by the cardiac surgery community.

CardioGenesis reports impressive results